VIMTA LABS
|
The Current P/S Ratio of VIMTA LABS is 5.03.
Share Price | ₹743.3 | Nov 19,2024 |
Market Cap | ₹1,650.0 Cr | |
Sales-TTM | ₹327.9 Cr | TTM-Consolidated Results |
Price/Sales | 5.03x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of VIMTA LABS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,650.0 Cr] as on Nov 19,2024
(/) Sales [ ₹327.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 5.03x ]
Thus, for VIMTA LABS , the investors are currently willing to pay '5.03 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of VIMTA LABS !
The chart below summarizes the trend in P/S Ratio of VIMTA LABS over the last five years.
Historical PS (Price/Sales) ratio chart of VIMTA LABS
PS Ratio Performance Analysis for VIMTA LABS
- VIMTA LABS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.04x.
- VIMTA LABS 's operated at median p/e ratio of 2.19x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VIMTA LABS 's p/e ratio peaked in Mar2024 at 3.1x.
- VIMTA LABS 's p/e ratio hit its five-year low in Mar2020 of 0.72x.
How does VIMTA LABS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
VIMTA LABS | 327.9 | 5.03 | 1,650.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.47 | 425,930.0 |
CIPLA LTD | 26,512.0 | 4.48 | 118,828.0 |
DR REDDYS LABORATORIES LTD | 30,084.9 | 3.37 | 101,290.0 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.44 | 95,280.3 |
DIVIS LABORATORIES LTD | 8,614.0 | 18.17 | 156,524.0 |
MANKIND PHARMA LTD | 11,018.0 | 9.34 | 102,890.0 |
TORRENT PHARMACEUTICALS LTD | 11,225.0 | 9.33 | 104,742.0 |
LUPIN LTD | 21,431.3 | 4.34 | 92,929.7 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.39 | 72,478.2 |
ABBOTT INDIA LTD | 6,066.1 | 9.53 | 57,784.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs VIMTA LABS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.39x |
Max industry PS | 18.17x |
Median industry PS | 5.03x |
Average industry PS | 7.17x |
You may also like the below Video Courses